False negative F-18 FDG PET/CT in nonsmall cell lung cancer bone metastases.
An, YS; Yoon, JK; Lee, MH; Joh, CW; Yoon, SN
Clinical nuclear medicine, 30(3):203-204, 2005
Clinical nuclear medicine
Tc-99m MDP bone scintigraphy is frequently performed for suspected skeletal metastases in lung cancer. F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) has also proved useful for staging nonsmall cell lung cancer, and it offers superior spatial resolution and improved specificity for bone metastases. Although F-18 FDG-PET is superior to Tc-99m MDP bone scintigraphy for the detection of bone metastases, the sensitivity for sclerotic (osteoblastic) metastases by F-18 FDG PET/CT is lower than for lytic metastases. These bone metastases may not be glycolytically active and may be below the requisite tumor mass needed for FDG accumulation. We describe the case of false-negative F-18 FDG PET/CT findings in a 57-year-old woman who demonstrated sclerotic bone metastases from nonsmall cell lung cancer. F-18 fluoride PET demonstrates a similar uptake pattern as Tc-99m MDP.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Total Visit :2,788,465
Total Download :1,137,004
Today View :354
Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312 / FAX : 031-219-5314 Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved. AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.